surufatinib
Showing 26 - 39 of 39
Advanced Colorectal Cancer Trial in Fuzhou (Surufatinib)
Recruiting
- Advanced Colorectal Cancer
- Surufatinib
-
Fuzhou, Fujian, ChinaChina, Fujian
Oct 27, 2021
Safety and Efficacy of Surufatinib in Treatment of Biliary Tract
Not yet recruiting
- Biliary Tract Carcinoma
- Surufatinib
- (no location specified)
Sep 22, 2021
Neuroendocrine Tumors, Non-hematologic Malignancy Trial in Japan (Surufatinib)
Recruiting
- Neuroendocrine Tumors
- Non-hematologic Malignancy
- Surufatinib
-
Fukuoka, Japan
- +11 more
Feb 1, 2022
Salivary Gland Carcinomas Trial in Shanghai (Surufatinib)
Recruiting
- Salivary Gland Carcinomas
- Surufatinib
-
Shanghai, ChinaShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Ton
Aug 16, 2021
Neuroendocrine Tumours, Neuroendocrine Tumour of the Lung, Small Intestinal NET Trial in Worldwide (Surufatinib)
Recruiting
- Neuroendocrine Tumours
- +2 more
- Surufatinib
-
Atlanta, Georgia
- +18 more
Mar 10, 2022
Neuroendocrine Tumors Trial in Beijing, Guangzhou, Chengdu (Surufatinib, Placebo)
Active, not recruiting
- Neuroendocrine Tumors
- Surufatinib
- Placebo
-
Beijing, Beijing, China
- +4 more
Aug 30, 2021
Head Neck Cancers - Salivary Gland Trial in Shanghai (Surufatinib)
Recruiting
- Head and Neck Cancers - Salivary Gland
- Surufatinib
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
May 28, 2021
Healthy Trial in Dallas (surufatinib)
Completed
- Healthy
- surufatinib
-
Dallas, TexasCovance Clinical Research Unit
May 20, 2021
Neuroendocrine Tumors Trial in Beijing, Guangzhou, Chengdu (Surufatinib, Placebo)
Active, not recruiting
- Neuroendocrine Tumors
- Surufatinib
- Placebo
-
Beijing, Beijing, China
- +4 more
Apr 13, 2021
Thyroid Cancer Trial in Shanghai (Surufatinib, Toripalimab)
Not yet recruiting
- Thyroid Cancer
- Surufatinib
- Toripalimab
-
Shanghai, China270 Dongan Road, Fudan University Shanghai Cancer Center
Aug 21, 2020
Biliary Tract Cancer Trial in Beijing (Surufatinib, Capecitabine)
Unknown status
- Biliary Tract Cancer
- Surufatinib
- Capecitabine
-
Beijing, Beijing, ChinaPLA 307 Hospital
Feb 12, 2020
Thyroid Carcinoma Trial in Beijing, Shanghai (Surufatinib)
Completed
- Thyroid Carcinoma
- Surufatinib
-
Beijing, Beijing, China
- +1 more
Feb 12, 2020
Biliary Tract Cancer Trial in China (Surufatinib)
Completed
- Biliary Tract Cancer
- Surufatinib
-
Beijing, Beijing, China
- +4 more
Feb 26, 2019